Loredana Marcu

Prof Loredana Marcu

School of Allied Health and Human Performance

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.


Dr. Loredana G. Marcu is currently a Professor of Medical Physics at the University of Oradea, Romania and Adjunct Professor at School of Health Sciences, University of South Australia. She received her PhD in Medical Physics from the University of Adelaide, and her Masters degree in Applied Physics from the West University of Timisoara, Romania. During her Australian experience she has coordinated the LDR brachytherapy programme at the Royal Adelaide Hospital. She was also a TEAP (Training Education and Accreditation Program) preceptor supervising and coordinating the medical physics training and education of the junior physicists in South Australia.
Her 20 years teaching experience at both Australian and Romanian universities has materialised in 14 books/book chapters published on physics, radiobiology and teaching methodologies, respectively, with other two books on Medical Physics being currently in press. She has written 5 textbooks and university lab guides and has over 140 publications and conference presentations worldwide. As a postgraduate coordinator, she has co-supervised 3 PhD students and supervised 21 MSc students. 
Dr. Marcu is involved in several professional activities being member of the Women in Medical Physics and Biomedical Engineering Task Group within IUPESM, national representative for Romania in EFOMP and IOMP and the vice-president of the Romanian College of Medical Physicists. She has been member/chair of the organising/scientific committee of 10 national and international conferences. Dr. Marcu has been awarded the title “Eminent Scientist of the year 2004” by the International Council for Research and she is the recipient of the “Boyce Worthley award 2006” given by the Australasian College of Physical Scientists and Engineers in Medicine for her achievements in the areas of radiobiology and medical physics.

Date Position Institution name
2012 - ongoing Professor University of Oradea

Date Institution name Country Title
2000 - 2005 University of Adelaide Australia PhD

Year Citation
2025 Costin, I. C., & Marcu, L. G. (2025). Impact of immobilization system angle, body mass index and breast size on breast radiotherapy accuracy using EPID-only setup. Heliyon, 11(3), 1-15.
DOI Scopus1 Europe PMC1
2025 Bezak, E., Sharrad, K. J., Marcu, L. G., Stoeva, M., Lhotska, L., Barabino, G., . . . Frize, M. (2025). A gender breakdown of unexpected benefits generated by work from home in STEM fields − a qualitative analysis of the WiMPBME Task Group survey. Physica Medica, 130, 1-5.
DOI
2025 Marcu, L. G., Marcu, D. C., Costin, I. C., Zahu, R., & Straciuc, O. (2025). From immunohistochemistry to machine learning-based patient stratification by tumour proliferation characteristics in head and neck cancer. Critical Reviews in Oncology Hematology, 216, 10 pages.
DOI
2025 Marcu, L. G., & Marcu, D. C. (2025). Examining the role of AI in cancer imaging through the lens of clinical studies. Health And Technology, online(6), 1-10.
DOI Scopus1 WoS1
2025 Costin, I. C., Marcu, L. G., Marcu, D. C., Zahu, R., & Straciuc, O. (2025). Is the use of machine learning in head and neck cancer radiotherapy supported by clinical trials?. Physica Medica, 136(105036), 17 pages.
DOI
2025 Coc, F. L., & Marcu, L. G. (2025). From CBCT to MR-Linac in image-guided prostate cancer radiotherapy towards treatment personalization. Current Oncology, 32(6, article no. 291), 1-20.
DOI
2025 Gazsi, I., & Marcu, L. G. (2025). The impact of pre-treatment image guidance on tumor and normal tissue dosimetry during VMAT for cervical cancer. Romanian Journal of Physics, 70(1-2, article no. 701), 1-17.
DOI
2025 Gazsi, I., & Marcu, L. G. (2025). Systematic review of SBRT boost for cervical cancer patients who cannot benefit from brachytherapy. Current Oncology, 32(3, article no. 170), 1-19.
DOI Scopus2 WoS2 Europe PMC1
2025 Gazsi, I., & Marcu, L. G. (2025). Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection. Radiation And Environmental Biophysics, 64(2), 291-302.
DOI
2025 Catona, G. M., & Marcu, L. G. (2025). Qualitative and quantitative evaluation of the role of CBCT in rectal cancer radiotherapy. Radiologia Medica, 130(2), 150-160.
DOI Scopus5 WoS4 Europe PMC3
2024 Costin, I. C., & Marcu, L. G. (2024). Patient and treatment-related factors that influence dose to heart and heart substructures in left-sided breast cancer radiotherapy. Physica Medica, 128(104851), 1-20.
DOI Scopus1 WoS1 Europe PMC1
2024 Costin, I. C., Cinezan, C., & Marcu, L. G. (2024). Cardio-oncology concerns in radiotherapy: Heart and cardiac substructure toxicities from modern delivery techniques. Critical Reviews in Oncology Hematology, 204(104538), 19 pages.
DOI Scopus5 WoS4 Europe PMC4
2024 Costin, I. C., & Marcu, L. G. (2024). Correlations between patient-specific parameters and dosimetric indices for personalized breast cancer radiotherapy. Scientific Reports, 14(1, article no. 26141), 1-19.
DOI
2024 Marcu, L. G., & Marcu, D. C. (2024). Pharmacogenomics and Big Data in medical oncology: developments and challenges. Therapeutic Advances in Medical Oncology, 16, 1-18.
DOI Scopus5 WoS6 Europe PMC3
2024 Ghemiș, D. M., & Marcu, L. G. (2024). RTOG 0915-compliant patient specific QA for lung stereotactic body radiotherapy using the new PTW 1600SRS detector array. Physica Medica, 127(104822), 1-8.
DOI
2024 Buciuman, N., Dasu, A., & Marcu, L. G. (2024). Dosimetric evaluation of intensity modulated photon versus proton reirradiation of head and neck cancer. Physica Medica, 123, 1-10.
DOI
2024 Costin, I. C., & Marcu, L. G. (2024). Affinity of PET-MRI tracers for hypoxic cells in breast cancer: a systematic review. Cells, 13(12, article no. 1048), 1-14.
DOI Scopus4 WoS1 Europe PMC2
2024 Costin, I. C., & Marcu, L. G. (2024). Evaluation of heart substructures as a function of dose and radiation-induced toxicities in left-sided breast cancer radiotherapy. European Journal of Cancer Care, 2024(1294250), 1-12.
DOI Scopus5 WoS4
2024 Marcu, L. G. (2024). Circadian rhythm-based cancer therapy in randomised clinical trials. Expert Review of Anticancer Therapy, 24(1-2), 29-39.
DOI Scopus8 WoS8 Europe PMC6
2024 Abbott, N. L., Chauvie, S., Marcu, L., DeJean, C., Melidis, C., Wientjes, R., . . . Hansen, C. R. (2024). The role of medical physics experts in clinical trials: a guideline from the European Federation of Organisations for Medical Physics. Physica Medica, 126(104821), 1-16.
DOI
2023 Byrne, B., Marcu, L., Mazzoni, L. N., Caruana, C. J., Barry, A., Martin, G. M., . . . Gilligan, P. (2023). EFOMP Malaga Declaration 2023: An updated vision on Medical Physics in Europe. Physica Medica-European Journal Of Medical Physics, 111(102620), 1-3.
DOI
2023 Ebert, A., Short, M., Pule, L., Marcu, L., & Buckely, E. (2023). Variations in patterns of care of rectal cancer patients in South Australia according to sociodemographic characteristics: a registry study. European Journal of Cancer Care, 2023(7974059), 1-7.
DOI
2023 Caruana, C. J., Amos, R. A., Burgos, D., Heukelom, S., Jeremic, M. Z., Julkunen, P., . . . Pesznyak, C. (2023). EFOMP policy statement 18: medical physics education for the non-physics healthcare professions. Physica Medica, 111(102602), 1-4.
DOI
2023 Marcu, L. G., Moghaddasi, L., & Bezak, E. (2023). Cannot target what cannot be seen: molecular imaging of cancer stem cells. International Journal of Molecular Sciences, 24(2, article no. 1524), 1-17.
DOI Scopus7 WoS6 Europe PMC6
2023 Bezak, E., Borrás, C., Hasford, F., Karmaker, N., Keyser, A., Stoeva, M., . . . Marcu, L. G. (2023). Science diplomacy in medical physics - an international perspective. Health and Technology, 13(3), 495-503.
DOI Scopus6 WoS5 Europe PMC5
2023 Marcu, L. G., Dell'Oro, M., & Bezak, E. (2023). Opportunities in cancer therapies: deciphering the role of cancer stem cells in tumour repopulation. International Journal of Molecular Sciences, 24(24), 1-16.
DOI Scopus3 WoS4 Europe PMC3
2023 Gazsi, I., & Marcu, L. G. (2023). Dosimetric evaluation of the benefits of intensity modulated techniques in cervical cancer radiotherapy. Romanian Journal of Physics, 68(7-8), 1-13.
Scopus2 WoS2
2023 Buciuman, N., & Marcu, L. G. (2023). Dosimetric and clinical aspects of head and neck cancer reirradiation with intensity modulated radiotherapy techniques over the last decade. Physica Medica-European Journal Of Medical Physics, 112(102650), 1-9.
DOI Scopus1 WoS1
2023 Ghemis, D. M., Marcu, L. G., Virag, V., & Virag, A. (2023). Dosimetric characteristics of 6MV flattening filter free and flattened beams among beam-matched linacs: a three-institutional study. Radiation Oncology, 18(1, article no. 126), 1-11.
DOI Scopus6 WoS6 Europe PMC3
2023 Marcu, D. C., Grava, C., & Marcu, L. G. (2023). Current role of delta radiomics in head and neck oncology. International Journal of Molecular Sciences, 24(3), 1-11.
DOI Scopus19 WoS17 Europe PMC18
2023 Ghemiș, D. M., & Marcu, L. G. (2023). Dosimetric parameters in hypofractionated stereotactic radiotherapy for brain metastases: do flattening filter-free beams bring benefits? A preliminary study. Cancers, 15(3), 1-12.
DOI Scopus1 WoS1 Europe PMC1
2022 Irazola, L., Marcu, L. G., & Koutsouveli, E. (2022). Early career medical physicists' section at the 4th European Congress of Medical Physics. Physica medica, 103, 74-75.
DOI Scopus3 WoS3 Europe PMC2
2022 Marcu, L. G. (2022). Developments on tumour site-specific chrono-oncology towards personalised treatment. Critical Reviews in Oncology / Hematology, 179(103803), 1-10.
DOI Scopus4 WoS4 Europe PMC3
2022 Costin, I. C., & Marcu, L. G. (2022). Factors impacting on patient setup analysis and error management during breast cancer radiotherapy. Critical Reviews in Oncology/Hematology, 178(103798), 1-13.
DOI Scopus14 WoS15 Europe PMC10
2022 Marcu, L. G., Abbott, N. L., Appelt, A., Chauvie, S., Gasnier, A., Hansen, C. R., . . . O'Doherty, J. (2022). The role of medical physicists in clinical trials across Europe. Physica Medica, 100, 31-38.
DOI Scopus2 WoS3 Europe PMC2
2022 Buciuman, N., & Marcu, L. G. (2022). Adaptive radiotherapy in head and neck cancer using volumetric modulated arc therapy. Journal of Personalized Medicine, 12(5), 1-13.
DOI Scopus10 WoS11 Europe PMC8
2022 Buciuman, N., & Marcu, L. G. (2022). Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?. European Archives of Oto-Rhino-Laryngology, 279(11), 5311-5321.
DOI Scopus5 WoS3 Europe PMC1
2022 Marcu, L. G., Caruana, C. J., Lopez Medina, A., Mazzoni, L. N., Polycarpou, I., Manetou, A., & Koutsouveli, E. (2022). Early career medical physicist groups in Europe: an EFOMP survey. Physica Medica, 95, 89-93.
DOI Scopus9 WoS7 Europe PMC2
2022 Marcu, L. G. (2022). Gender and sex-related differences in normal tissue effects induced by platinum compounds. Pharmaceuticals, 15(2, article no. 255), 1-14.
DOI Scopus22 WoS19 Europe PMC18
2022 Bezak, E., Carson Chahhoud, K. V., Marcu, L. G., Stoeva, M., Lhotska, L., Barabino, G. A., . . . Frize, M. (2022). The biggest challenges resulting from the COVID-19 pandemic on gender-related work from home in biomedical fields: world-wide qualitative survey analysis. International Journal of Environmental Research and Public Health, 19(5), 1-16.
DOI Scopus21 WoS17 Europe PMC10
2022 Moghaddasi, L., Reid, P., Bezak, E., & Marcu, L. G. (2022). Radiobiological and treatment-related aspects of spatially fractionated radiotherapy. International Journal of Molecular Sciences, 23(6, article no. 3366), 1-21.
DOI Scopus42 WoS40 Europe PMC30
2022 Frize, M., Tsapaki, V., Lhotska, L., da Silva, A. M. M., Ibrahim, F., Bezak, E., . . . Marcu, L. G. (2022). Women in medical physics and biomedical engineering: past, present and future. Health and Technology, 12(3), 655-662.
DOI Scopus3 WoS2 Europe PMC2
2022 Marcu, L. G., Bezak, E., & Sykes, P. J. (2022). Radiation research journals need to stipulate minimal dosimetry requirements for publishing research using x-radiation exposures. Radiation Research, 198(2), 204-206.
DOI Scopus5 WoS5 Europe PMC5
2021 Marcu, L. G., Bezak, E., Peukert, D. D., & Wilson, P. (2021). Translational Research in FLASH Radiotherapy—From Radiobiological Mechanisms to In Vivo Results. Biomedicines, 9(2), 1-15.
DOI Scopus35 WoS29 Europe PMC23
2021 Marcu, L. G., Chau, M., & Bezak, E. (2021). How much is too much? Systematic review of cumulative doses from radiological imaging and the risk of cancer in children and young adults.. Critical reviews in oncology/hematology, 160(103292), 103292.
DOI Scopus27 WoS25 Europe PMC22
2021 Frize, M., Lhotska, L., Marcu, L. G., Stoeva, M., Barabino, G., Ibrahim, F., . . . Bezak, E. (2021). The impact of COVID-19 pandemic on gender-related work from home in STEM fields-Report of the WiMPBME Task Group. Gender, Work and Organization, 28(S2), 378-396.
DOI Scopus31 WoS25 Europe PMC15
2021 Li, Y., Marcu, L. G., Hull, A., & Bezak, E. (2021). Radioimmunotherapy of glioblastoma multiforme - Current status and future prospects. Critical Reviews in Oncology/Hematology, 163(103395), 1-18.
DOI Scopus18 WoS14 Europe PMC13
2021 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2021). Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose. Head and Neck, 43(10), 3086-3096.
DOI Scopus1 WoS1 Europe PMC1
2021 Marcu, L. G., & Marcu, D. C. (2021). Current omics trends in personalised head and neck cancer chemoradiotherapy. Journal of Personalized Medicine, 11(11, article no. 1094), 1-13.
DOI Scopus11 WoS10 Europe PMC12
2021 Buciuman, N., & Marcu, L. G. (2021). Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer—a systematic review of the literature. Laryngoscope Investigative Otolaryngology, 6(5), 999-1007.
DOI Scopus20 WoS17 Europe PMC13
2021 Ghemiş, D. M., & Marcu, L. G. (2021). Progress and prospects of flattening filter free beam technology in radiosurgery and stereotactic body radiotherapy. Critical Reviews in Oncology/Hematology, 163(103396), 1-10.
DOI Scopus13 WoS14 Europe PMC8
2021 Casares Magaz, O., Marcu, L. G., Prezado, Y., Koutsouveli, E., & Brambilla, M. (2021). EFOMP survey results on national radiotherapy dosimetry audits. Physica Medica, 84, 10-14.
DOI Scopus7 WoS7 Europe PMC4
2021 Bodale, M., & Marcu, L. G. (2021). 140 years of medical physics in Romania. Physica Medica, 82, 46-53.
DOI
2021 Marcu, L. G., & Marcu, D. (2021). Points of view on artificial intelligence in medical imaging-one good, one bad, one fuzzy. Health and Technology, 11(1), 17-22.
DOI Scopus13 WoS10
2021 Marcu, L. (2021). COVID-19 vaccination rates of medical physicists throughout Europe. Physica Medica, 28, 341-342.
DOI
2020 Marcu, L. G. (2020). The ever-changing role of medical physicists in the era of personalized medicine. Journal of Medical Physics, 45(4), 197-198.
DOI Scopus3 Europe PMC4
2020 Dinu, A., Flonta, T., & Marcu, L. G. (2020). The impact of breast irradiation using thermoplastic mask on treatment delivery and acute effects. Romanian Reports in Physics, 72(2, article no. 603), 1-11.
2020 Marcu, L. G. (2020). Imaging biomarkers of tumour proliferation and invasion for personalised lung cancer therapy. Journal of Personalized Medicine, 10(4), 1-17.
DOI Scopus10 WoS8 Europe PMC6
2020 Marcu, L. G. (2020). Cancer stem cells as therapeutic targets of pancreatic cancer. Fundamental and Clinical Pharmacology, 34(2), 202-212.
DOI Scopus8 WoS6 Europe PMC6
2020 Al Darwish, R., Marcu, L., & Bezak, E. (2020). Overview of current applications of the Timepix detector in spectroscopy, radiation and medical physics. Applied Spectroscopy Reviews, 55(3), 243-261.
DOI Scopus6 WoS7
2020 De Courcy, L., Bezak, E., & Marcu, L. G. (2020). Gender-dependent radiotherapy: The next step in personalised medicine?. Critical Reviews in Oncology/Hematology, 147(102881), 102881-1-102881-8.
DOI Scopus60 WoS55 Europe PMC45
2020 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2020). Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers. Scientific Reports, 10(1), 1-8.
DOI Scopus12 WoS13 Europe PMC10
2020 Wong, H. Y., Marcu, L. G., Bezak, E., & Parange, N. A. (2020). Review of health economics of point-of-care testing worldwide and its efficacy of implementation in the primary health care setting in remote Australia. Risk Management and Healthcare Policy, 13, 379-386.
DOI Scopus15 WoS12 Europe PMC13
2020 Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., . . . Bezak, E. (2020). Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers.. Cells, 9(8), 1-14.
DOI Scopus7 WoS7 Europe PMC6
2019 Marcu, L. G., Boyd, C., & Bezak, E. (2019). Feeding the data monster: data science in head and neck cancer for personalized therapy. Journal of the American college of radiology, 16(12), 1695-1701.
DOI Scopus9 WoS6 Europe PMC2
2019 Marcu, L., Boyd, C., & Bezak, E. (2019). Current issues regarding artificial intelligence in cancer and health care. Implications for medical physicists and biomedical engineers. Health and Technology, 9(4), 375-381.
DOI Scopus12 WoS11
2019 Forster, J. C., Marcu, L. G., & Bezak, E. (2019). Approaches to combat hypoxia in cancer therapy and the potential for in silico models in their evaluation. Physica Medica, 64, 145-156.
DOI Scopus23 WoS21 Europe PMC14
2019 Marcu, L. G., Forster, J. C., & Bezak, E. (2019). The Potential Role of Radiomics and Radiogenomics in Patient Stratification by Tumor Hypoxia Status. Journal of the American College of Radiology, 16(9), 1329-1337.
DOI Scopus14 WoS14 Europe PMC10
2019 Huynh, M., Marcu, L. G., Giles, E., Short, M., Matthews, D., & Bezak, E. (2019). Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system? A review of current evidence. Radiotherapy and Oncology, 133, 140-148.
DOI Scopus16 WoS15 Europe PMC12
2019 Reid, P., Marcu, L. G., Olver, I., Moghaddasi, L., Staudacher, A. H., & Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiotherapy and Oncology, 135, 1-12.
DOI Scopus33 WoS30 Europe PMC25
2019 Barabino, G., Frize, M., Ibrahim, F., Kaldoudi, E., Lhotska, L., Marcu, L., . . . Bezak, E. (2019). Solutions to Gender Balance in STEM Fields Through Support, Training, Education and Mentoring: Report of the International Women in Medical Physics and Biomedical Engineering Task Group. Science and Engineering Ethics, 26(1), 275-292.
DOI Scopus28 WoS26 Europe PMC12
2019 Marcu, L. G., & Marcu, D. (2019). The role of hypofractionated radiotherapy in the management of head and neck cancer - a modelling approach. Journal of theoretical biology, 482(article no. 109998), 1-9.
DOI Scopus7 WoS6 Europe PMC5
2018 Morias, S., Marcu, L., Short, M., Giles, E., & Bezak, E. (2018). Do SABR-related toxicities for lung cancer depend on treatment delivery?. Critical Reviews in Oncology/Hematology, 129, 67-78.
DOI Scopus1 WoS1 Europe PMC1
2018 Marcu, L., Reid, P., & Bezak, E. (2018). The promise of novel biomarkers for head and neck cancer from an imaging perspective. International Journal of Molecular Sciences, 19(9), 15 pages.
DOI Scopus21 WoS20 Europe PMC18
2018 Huynh, M., Marcu, L. G., Giles, E., Short, M., Matthews, D., & Bezak, E. (2018). Current status of proton therapy outcome for paediatric cancers of the central nervous system – Analysis of the published literature. Cancer Treatment Reviews, 70, 272-288.
DOI Scopus20 WoS16 Europe PMC11
2018 Morias, S., Marcu, L. G., Short, M., Giles, E., Potter, A., Shepherd, J., . . . Bezak, E. (2018). Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy. Journal of Oncology, 2018(6483626), 16 pages.
DOI Scopus19 WoS16 Europe PMC11
2018 Marcu, L., Bezak, E., & Allen, B. (2018). Global comparison of targeted alpha vs targeted beta therapy for cancer: in vitro, in vivo and clinical trials. Critical Reviews in Oncology/Hematology, 123, 7-20.
DOI Scopus121 WoS101 Europe PMC76
2018 Reid, P., Wilson, P., Li, Y., Marcu, L., Staudacher, A., Brown, M., & Bezak, E. (2018). Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay. Scientific Reports, 8(1), 7 pages.
DOI Scopus10 WoS9 Europe PMC5
2018 Marcu, L., Moghaddasi, L., & Bezak, E. (2018). Imaging of tumor characteristics and molecular pathways with PET: developments over the last decade toward personalized cancer therapy. International Journal of Radiation Oncology: Biology, Physics, 102(4), 1165-1182.
DOI Scopus36 WoS33 Europe PMC25
2017 Marcu, L. G. (2017). Photons - Radiobiological issues related to the risk of second malignancies. Physica Medica, 42, 1-8.
DOI Scopus25 WoS22 Europe PMC17
2017 Bezak, E., Takam, R., Yeoh, E., & Marcu, L. (2017). The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy. Physica Medica, 42, 253-258.
DOI Scopus19 WoS15 Europe PMC13
2017 So, B., Marcu, L. G., Olver, I., Gowda, R., & Bezak, E. (2017). Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas. Acta Oncologica, 56(7), 899-908.
DOI Scopus3 WoS3 Europe PMC2
2017 Marcu, L. G., & Marcu, D. (2017). The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model. Cell proliferation, 50(6, article no. e12380), 1-9.
DOI Scopus4 WoS5 Europe PMC4
2017 Reid, P., Wilson, P., Li, Y., Marcu, L. G., Staudacher, A. H., Brown, M. P., & Bezak, E. (2017). In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status. PLoS ONE, 12(10), 16 pages.
DOI Scopus20 WoS18 Europe PMC17
2016 Chirla, R., & Marcu, L. G. (2016). PET-based quantification of statistical properties of hypoxic tumor subvolumes in head and neck cancer. Physica Medica, 32(1), 23-35.
DOI Scopus20 WoS21 Europe PMC17
2016 Marcu, L., Marcu, D., & Filip, S. (2016). In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy. Cell Proliferation, 49(3), 304-314.
DOI Scopus13 WoS12 Europe PMC8
2016 Marcu, L. G. (2016). Future treatment directions for HPV-associated head and neck cancer based on radiobiological rationale and current clinical evidence. Critical Reviews in Oncology/Hematology, 103, 27-36.
DOI Scopus21 WoS19 Europe PMC17
2016 Santos, A., Marcu, L., Wong, C., & Bezak, E. (2016). Risk estimation of second primary cancers after breast radiotherapy. Acta Oncologica, 55(11), 1331-1337.
DOI Scopus30 WoS25 Europe PMC21
2016 Marcu, L. G., & Marcu, D. (2016). In silico modelling of a cancer stem cell-targeting agent and its effects on tumour control during radiotherapy. Scientific reports, 6(1), 1-8.
DOI Scopus17 WoS14 Europe PMC9
2015 Bezak, E., Takam, R., & Marcu, L. (2015). Peripheral photon and neutron doses from prostate cancer external beam irradiation. Radiation Protection Dosimetry, 167(4), 591-601.
DOI Scopus11 WoS7 Europe PMC2
2015 Jennings, M., Marcu, L., & Bezak, E. (2015). PET-specific parameters and radiotracers in theoretical tumour modelling. Computational and Mathematical Methods in Medicine, 2015(415923), 415923-1-415923-11.
DOI Scopus10 WoS10 Europe PMC8
2015 Marcu, L. G., Bezak, E., Toma-Dasu, I., & Dasu, A. (2015). Predictive models of tumour response to treatment using functional imaging techniques. Computational and Mathematical Methods in Medicine, 2015, 571371-1-571371-2.
DOI Scopus2 WoS1 Europe PMC2
2015 Marcu, L. G. (2015). The first Rs of radiotherapy: or standing on the shoulders of giants. Australasian physical and engineering sciences in medicine, 38(4), 531-541.
DOI Scopus4 WoS3 Europe PMC3
2014 Marcu, L., Santos, A., & Bezak, E. (2014). Risk of second primary cancer after breast cancer treatment. European Journal of Cancer Care, 23(1), 51-64.
DOI Scopus33 WoS32 Europe PMC25
2014 Marcu, L., Harriss-Phillips, W., & Filip, S. (2014). Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach. Computational and Mathematical Methods in Medicine, 2014, 624642-1-624642-13.
DOI Scopus7 WoS7 Europe PMC7
2014 Marcu, L. (2014). Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy. Cell Proliferation, 47(4), 318-325.
DOI Scopus8 WoS8 Europe PMC8
2013 Marcu, L. (2013). Improving therapeutic ratio In head and neck cancer with adjuvant and cisplatin-based treatments. BioMed Research International, 2013, 1-9.
DOI Scopus10 WoS8 Europe PMC6
2013 Rutten, T., Lawson, J., & Marcu, L. (2013). Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution. Physica Medica, 29(6), 662-669.
DOI Scopus6 WoS6 Europe PMC5
2013 Marcu, L., & Lawson, J. (2013). Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants. British Journal of Radiology, 86(1026), 130058-1-130058-10.
DOI Scopus4 WoS3 Europe PMC2
2013 Marcu, L., & Gowda, R. (2013). Comparison of 3 different postimplant dosimetry methods following permanent ¹²⁵I prostate seed brachytherapy. Medical Dosimetry, 38(3), 309-314.
DOI Scopus7 WoS7 Europe PMC5
2013 Allen, B., Bezak, E., & Marcu, L. (2013). Quo vadis radiotherapy? Technological advances and the rising problems in cancer management. BioMed Research International, 2013(749203), 1-9.
DOI Scopus11 WoS9 Europe PMC9
2012 Moorrees, J., Lawson, J., & Marcu, L. (2012). Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy. Radiation Oncology, 7(196), 1-9.
DOI Scopus3 WoS3 Europe PMC1
2012 Moghaddasi, F., Bezak, E., & Marcu, L. (2012). Current challenges in clinical target volume definition: tumour margins and microscopic extensions. Acta Oncologica, 51(8), 984-995.
DOI Scopus24 WoS22 Europe PMC21
2012 Marcu, L., & Bezak, E. (2012). Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer. Cell Proliferation, 45(5), 404-412.
DOI Scopus5 WoS5 Europe PMC5
2012 Marcu, L., & Harriss-Phillips, W. (2012). In silico modelling of treatment-induced tumour cell kill: Developments and advances. Computational and Mathematical Methods in Medicine, 2012, 1-16.
DOI Scopus23 WoS20 Europe PMC17
2012 Moghaddasi, F., Bezak, E., & Marcu, L. (2012). In silico modelling of tumour margin diffusion and infiltration: Review of current status. Computational and Mathematical Methods in Medicine, 2012(672895), 1-12.
DOI Scopus10 WoS8 Europe PMC7
2012 Penfold, S., Marcu, L., Lawson, J., & Asp, J. (2012). Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer. Journal of Radiological Protection, 32(3), 339-347.
DOI Scopus3 WoS3 Europe PMC1
2012 Marcu, L., Lawson, J., Rutten, T., & Gowda, R. (2012). Quality indicators and technique for analyzing permanent I-125 prostate seed implants: Seven years postimplant dosimetry evaluation. Medical Physics, 39(7), 4123-4131.
DOI Scopus7 WoS6 Europe PMC6
2012 Takam, R., Bezak, E., Liu, G., & Marcu, L. (2012). The use of enriched ⁶Li and ⁷Li Lif:Mg,Cu,P glass-rod thermoluminescent dosemeters for linear accelerator out-of-field radiation dose measurements. Radiation Protection Dosimetry, 150(1), 22-33.
DOI Scopus10 WoS11 Europe PMC2
2012 Marcu, L., Bezak, E., & Filip, S. (2012). The role of PET imaging in overcoming radiobiological challenges in the treatment of advanced head and neck cancer. Cancer Treatment Reviews, 38(3), 185-193.
DOI Scopus6 WoS5 Europe PMC4
2012 Marcu, L., & Bezak, E. (2012). Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio. Journal of Theoretical Biology, 297, 41-47.
DOI Scopus7 WoS6 Europe PMC4
2012 Bezak, E., Marcu, L., & Penfold, S. (2012). Computational and mathematical modeling of tumor kinetics and response to radiation and chemotherapy. Computational and Mathematical Methods in Medicine, 2012, 702675-1-702675-2.
DOI
2011 Takam, R., Bezak, E., Marcu, L., & Yeoh, E. (2011). Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: Current status. Radiation Research, 176(4), 508-520.
DOI Scopus46 WoS45 Europe PMC30
2010 Marcu, L., & Yeoh, E. (2010). The emerging role of predictive assays in the management of head and neck cancer. Austral-Asian Journal of Cancer, 9(2), 71-77.
2010 Marcu, L., & Bezak, E. (2010). Modelling of tumour repopulation after chemotherapy. Australasian Physical and Engineering Sciences in Medicine, 33(3), 265-270.
DOI Scopus12 WoS12 Europe PMC12
2010 Takam, R., Bezak, E., Yeoh, E., & Marcu, L. (2010). Assessment of normal tissue complications following prostate cancer irradiation: Comparison of radiation treatment modalities using NTCP models. Medical Physics, 37(9), 5126-5137.
DOI Scopus26 WoS25 Europe PMC20
2010 Marcu, L., & Bezak, E. (2010). Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer. Physica Medica, 26(4), 177-183.
DOI Scopus4 WoS3 Europe PMC4
2010 Marcu, L. (2010). Altered fractionation in radiotherapy: From radiobiological rationale to therapeutic gain. Cancer Treatment Reviews, 36(8), 606-614.
DOI Scopus37 WoS32 Europe PMC29
2009 Marcu, L., & Bezak, E. (2009). Radiobiological modeling of interplay between accelerated repopulation and altered fractionation schedules in head and neck cancer. Journal of Medical Physics, 34(4), 206-211.
DOI Scopus17 WoS16 Europe PMC12
2009 Marcu, L., & Yeoh, E. (2009). A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. Journal of Cancer Research and Clinical Oncology, 135(10), 1303-1314.
DOI Scopus61 WoS57 Europe PMC48
2009 Marcu, L. (2009). The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy. European Journal of Cancer Care, 18(2), 116-123.
DOI Scopus13 WoS13 Europe PMC10
2008 Harriss-Phillips, W., Bezak, E., Yeoh, E., & Marcu, L. (2008). Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer. Physics in Medicine and Biology, 53(17), 4489-4507.
DOI Scopus17 WoS16 Europe PMC11
2006 Marcu, L., Bezak, E., & Olver, I. (2006). Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Physics in Medicine and Biology, 51(15), 3625-3639.
DOI Scopus30 WoS27 Europe PMC25
2006 Marcu, L., & Olver, I. (2006). Tirapazamine: from bench to clinical trials. Current Clinical Pharmacology, 1(1), 71-79.
DOI Scopus105 WoS102 Europe PMC77
2006 Marcu, L., & Quach, K. (2006). The role of post-implant dosimetry in the quality assessment of prostate implants. The RAH experience. Australasian Physical and Engineering Sciences in Medicine, 29(4), 310-314.
DOI
2005 Marcu, L., Bezak, E., Olver, I., & Van Doorn, T. (2005). Tumour resistance to cisplatin: a modelling approach. Physics in Medicine and Biology, 50(1), 93-102.
DOI Scopus21 WoS20 Europe PMC15
2004 Marcu, L., Van Doorn, T., & Olver, I. (2004). Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Physics in Medicine and Biology, 49(16), 3767-3779.
DOI Scopus36 WoS34 Europe PMC31
2004 Marcu, L., Lyons, A., Bezak, E., & Van Doorn, T. (2004). The onset of tumour repopulation after radiotherapy in theoretical and in vitro models. Austral-Asian Journal of Cancer, 3(3), 167-171.
2003 Marcu, L., Van Doorn, T., & Olver, I. (2003). Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer - a review of their cooperation. Acta Oncologica, 42(4), 315-325.
DOI Scopus60 WoS53 Europe PMC47

Year Citation
2015 Marcu, L. G. (Ed.) (2015). Contemporary Issues in Head and Neck Cancer Management. In . InTech.
DOI
2015 Marcu, L. G. (Ed.) (2015). Contemporary Issues in Head and Neck Cancer Management. In . InTech.
DOI
2015 Marcu, L. G. (Ed.) (2015). Contemporary Issues in Head and Neck Cancer Management. In . InTech.
DOI
2012 Marcu, L. G., & Yeoh, E. (2012). Tumour Repopulation During Treatment for Head and Neck Cancer: Clinical Evidence, Mechanisms and Minimizing Strategies. In L. G. Marcu, & E. Yeoh (Eds.), Tumour Repopulation During Treatment for Head and Neck Cancer: Clinical Evidence, Mechanisms and Minimizing Strategies (pp. 253-272).

Connect With Me

External Profiles

Other Links